Clinical Trial Update: Adjunctive Doxycycline for Central Nervous System Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating adjunctive doxycycline for central nervous system tuberculosis (including tuberculous meningitis) is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis of the Central Nervous System
• Tuberculous Meningitis

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Tuberculosis, Meningeal, Tuberculosis; Meningitis (Etiology) | Phase 2 | Status: RECRUITING